Stock Research for STML

Current Price


Latest Update: 2018-03-19 16:00:00

$ 14.1000
$ 14.0500
$ 14.1000

Featured Broker: TradeStation

Get the due diligence for another stock.


STML Stock Chart & Research Data

The STML chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the STML chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


STML Due diligence Resources & Stock Charts

The STML stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View STML Detailed Price Forecast - CNN Money CNN View STML Detailed Summary - Google Finance
Yahoo View STML Detailed Summary - Yahoo! Finance Zacks View STML Stock Research & Analysis -

Stock Analysis

TradeIdeas View STML Trends & Analysis - Trade-Ideas Barrons View STML Major Holders - Barrons
NASDAQ View STML Call Transcripts - NASDAQ Seeking View STML Breaking News & Analysis - Seeking Alpha
Spotlight View STML Annual Report - OTC Report View STML OTC Short Report -
TradeKing View STML Fundamentals - TradeKing Charts View STML SEC Filings - Bar Chart
WSJ View Historical Prices for STML - The WSJ Morningstar View Performance/Total Return for STML - Morningstar
MarketWatch View the Analyst Estimates for STML - MarketWatch CNBC View the Earnings History for STML - CNBC
StockMarketWatch View the STML Earnings - StockMarketWatch MacroAxis View STML Buy or Sell Recommendations - MacroAxis
Bullish View the STML Bullish Patterns - American Bulls Short Pains View STML Short Pain Metrics -

Social Media Mentions

StockTwits View STML Stock Mentions - StockTwits PennyStocks View STML Stock Mentions - PennyStockTweets
Twitter View STML Stock Mentions - Twitter Invest Hub View STML Investment Forum News - Investor Hub
Yahoo View STML Stock Mentions - Yahoo! Message Board Seeking Alpha View STML Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for STML - Insider Cow View Insider Transactions for STML - Insider Cow
CNBC View STML Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for STML - OTC Markets
Yahoo View Insider Transactions for STML - Yahoo! Finance NASDAQ View Institutional Holdings for STML - NASDAQ

Stock Charts

FinViz View STML Stock Insight & Charts - StockCharts View STML Investment Charts -
BarChart View STML Stock Overview & Charts - BarChart Trading View View STML User Generated Charts - Trading View

Latest Financial News for STML

Report: Exploring Fundamental Drivers Behind Fluidigm, Acuity Brands, TTEC, Actuant, Equity Lifestyle Properties, and Stemline Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
Posted on Monday March 19, 2018

NEW YORK, March 19, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...

Stemline Therapeutics to Present at the Oppenheimer 28th Annual Healthcare Conference
Posted on Monday March 19, 2018

NEW YORK, March 19, 2018-- Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that Ivan Bergstein, M.D., Stemline’ s CEO, will ...

Stemline Therapeutics reports 4Q loss
Posted on Friday March 16, 2018

On a per-share basis, the New York-based company said it had a loss of 93 cents. For the year, the company reported that its loss widened to $67.8 million, or $2.94 per share. Revenue was reported as $898,000. ...

Stemline Therapeutics Reports Fourth Quarter 2017 Financial Results
Posted on Friday March 16, 2018

NEW YORK, March 16, 2018--. Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today financial results for the quarter ended December ...

Warning: DOMDocument::load(): StartTag: invalid element name in, line: 1 in /home/allsites/ on line 494

Warning: DOMDocument::load(): Extra content at the end of the document in, line: 1 in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.